| Financial Year |
March 31 2023 |
| Monetary Funds |
4,209,931,825.87 |
| Held-for-trading Financial Assets |
104,011,519.99 |
| Notes Receivable |
192,733,930.67 |
| Accounts Receivable |
3,394,213,944.45 |
| Advances to Suppliers |
554,577,413.72 |
| Other Receivables |
73,008,943.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,179,300,371.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,659,388.68 |
| Total Current Assets |
12,297,261,678.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
867,646,164.88 |
| Investment Properties |
-- |
| Fixed Assetes |
1,736,573,680.21 |
| Under-construction Projects |
70,879,782.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
259,059,391.48 |
| R&D expenses |
52,349,665.24 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
49,545,669.30 |
| Deferred Income Tax Assets |
123,981,474.91 |
| Other Non-Current Assets |
2,105,066,199.08 |
| Sub-Total of Non-Current Assets |
5,324,790,323.71 |
| Total Assets |
17,622,052,002.13 |
| Short-Term Loans |
346,464,025.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,617,635,395.90 |
| Accounts Payable |
2,735,881,621.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,151,063.71 |
| Taxes Payable |
107,178,277.31 |
| Interest Payable |
-- |
| Dividend Payable |
100,722,278.79 |
| Other payables |
214,407,569.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
721,296,063.05 |
| Other Current Liabilities |
53,505,611.77 |
| Sub-Total of Current Liabilities |
6,292,519,876.46 |
| Long-term Loans |
2,530,756,251.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
74,597,268.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,857,620,220.69 |
| Total Liabilities |
9,150,140,097.15 |
| Paid-In Capital(Or Share Stock) |
1,005,502,707.00 |
| Capital Surplus |
2,686,270,595.89 |
| Surplus Reserve |
148,336,561.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,593,518,004.60 |
| Minority Stockholder's Interest |
26,457,369.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,445,454,535.88 |
| Owner's Equity（Stockholder's Equity） |
8,471,911,904.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,622,052,002.13 |
